NEXTCURE INC(NASDAQ:NXTC) stock News

NXTC Latest News, Press Relases and Analysis

All

Press Releases

14 days ago - By: Chartmill - Mentions: DECK SNV EW FIX ...

Thursday's after hours session: top gainers and losers

5 hours ago - By: NextCure

NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results

5 hours ago - By: NextCure

NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results

13 days ago - By: Benzinga - Mentions: IVA PIII TTNP HCTI ...

12 Health Care Stocks Moving In Friday's Intraday Session

14 days ago - By: Benzinga - Mentions: CNC ZYXI XTLB SRPT ...

12 Health Care Stocks Moving In Friday's Pre-Market Session

14 days ago - By: NextCure

Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta

14 days ago - By: NextCure

Preclinical Data Demonstrate Anti-Siglec-15 Treatment Improves Bone Microarchitecture and Reduces Fracture Incidence in Mice with Moderate-to-Severe Osteogenesis Imperfecta

2 months ago - By: NextCure

NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6

2 months ago - By: NextCure

NextCure and Simcere Zaiming Announce Strategic Partnership for a Novel Antibody-Drug Conjugate Targeting CDH6

2 months ago - By: NextCure

NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025

2 months ago - By: NextCure

NextCure and LigaChemBio to Present Trial in Progress Poster for LNCB74, a B7-H4 Targeted Antibody-Drug Conjugate, as Monotherapy in Participants with Advanced Solid Tumors at ASCO 2025

2 months ago - By: Yahoo Finance - Mentions: GAP TAL GOOS GOOG ...

The Gap, Inc. (GAP) Is A “Star,” Says Jim Cramer

2 months ago - By: Yahoo Finance - Mentions: GOOS TAL AXP NVDA ...

Canada Goose Holdings Inc. (GOOS) Has Been “Terrific,” Says Jim Cramer

3 months ago - By: NextCure

NextCure Provides Business Update and Reports First Quarter 2025 Financial Results

3 months ago - By: NextCure

NextCure Provides Business Update and Reports First Quarter 2025 Financial Results

4 months ago - By: NextCure

NextCure to Present at 24th Annual Needham Virtual Healthcare Conference

4 months ago - By: NextCure

NextCure to Present at 24th Annual Needham Virtual Healthcare Conference

5 months ago - By: NextCure

NextCure Provides Business Update and Reports Full Year 2024 Financial Results

5 months ago - By: NextCure

NextCure Provides Business Update and Reports Full Year 2024 Financial Results

7 months ago - By: NextCure

NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers

7 months ago - By: NextCure

NextCure Announces First Patient Dosed in the Phase 1 Study of LNCB74 (B7-H4 ADC) as Therapeutic for Treating Multiple Cancers

8 months ago - By: NextCure

NextCure Announces Acceptance of IND Application for LNCB74

8 months ago - By: NextCure

NextCure Announces Acceptance of IND Application for LNCB74

8 months ago - By: NextCure

NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference

8 months ago - By: NextCure

NextCure to Participate in the 36th Annual Piper Sandler Healthcare Conference

9 months ago - By: NextCure

Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta

9 months ago - By: NextCure

Preclinical Data Demonstrates Anti-Siglec-15 Treatment Enhanced Generation of Quality Bone with Better Mechanical Properties in Mice with Moderate-to-Severe Osteogenesis Imperfecta

NEXTCURE INC (NXTC) Stock News

NXTC Latest News, Press Relases and Analysis